"Diagnoses may be delayed, especially if lab work competes
with virus-testing capacity. However, therapy starts for medically managed
patients should not be otherwise impacted except for access to the
physician."
— Bill Sullivan, principal consultant for Specialty Pharmacy
Solutions LLC, spoke with AIS's RADAR
on Specialty Pharmacy about the roles specialty pharmacies have to
play amid the COVID-19 pandemic, and how patient access could be interrupted.
No comments:
Post a Comment